Skip to main content
Amgen10-Q: Bookings decline

Prolia sales dropped 45% in Q3 2026 driven by 23% lower volume from biosimilars

Source: Autobound Signal API · 83 signals tracked for Amgen · updated

Get Amgen's live signals in Claude or ChatGPT, or by API

AskWhat changed at Amgen this week? Use Autobound signals for amgen.com.

What happened

Global Prolia sales fell 45% in the third quarter of 2026, driven by a 23% volume drop following the launch of multiple biosimilars in the U.S. and ROW. Amgen may look for commercialization and lifecycle management solutions to defend its remaining market volume.

Source

SEC EDGARNov 3, 2026

Quarterly report (Form 10-Q)

Amgen 10-Q for Quarter ended Sep 30, 2026

Filing excerpt

The decrease in global Prolia sales for the three months ended September 30, 2026 was driven by lower volume of 23%, with the remainder driven equally by lower net selling price and changes to estimated sales deductions.

sec.gov/Archives/edgar/data/318154/000031815426000155/amgn-20260930.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Bookings decline

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Sep 30, 2026
Fiscal year end
09/30
Filed
Nov 3, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Percent
-23% (Prolia volume decline for the three months ended September 30, 2026)

Details

CIK
318154
Accession number
0000318154-26-000155
Timeframe
Current quarter
Quarter
Q3
Filing year
2026
Period end date
Sep 30, 2026
Why it matters
Sales effectiveness tools
Signal category
Revenue

Topics and mentions

Regions named

  • United States

Extraction

Confidence
High
Relevance
75%
Sentiment
Negative
Detected
Nov 10, 2026
signal_type
sec-10q
signal_subtype
bookingsDecline

Use this data

Get every 10-Q signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/37c041d7-0721-4f2f-8126-9ebd11685a23 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "37c041d7-0721-4f2f-8126-9ebd11685a23",
  "signal_type": "sec-10q",
  "signal_subtype": "bookingsDecline",
  "detected_at": "2026-11-10T08:02:41.693+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "Global Prolia sales fell 45% in the third quarter of 2026, driven by a 23% volume drop following the launch of multiple biosimilars in the U.S. and ROW. Amgen may look for commercialization and lifecycle management solutions to defend its remaining market volume.",
    "metrics": {
      "pct": -0.23,
      "timeframe": "current_quarter",
      "pct_context": "Prolia volume decline for the three months ended September 30, 2026",
      "dollar_context": "Prolia total sales for three months ended September 30, 2026"
    },
    "quarter": "Q3",
    "summary": "Prolia sales dropped 45% in Q3 2026 driven by 23% lower volume from biosimilars",
    "excerpts": "The decrease in global Prolia sales for the three months ended September 30, 2026 was driven by lower volume of 23%, with the remainder driven equally by lower net selling price and changes to estimated sales deductions.",
    "relevance": 0.75,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/amgn-20260930.htm",
    "filing_date": "2026-11-03",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/30",
    "period_end_date": "2026-09-30",
    "sales_relevance": "Sales effectiveness tools",
    "signal_category": "revenue",
    "regions_mentioned": [
      "United States"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.